Types of Cardiac Amyloidosis
There are two types of cardiac amyloidosis, differentiated by the specific protein being deposited in the heart tissue.
AL Amyloidosis
Also called immunoglobulin light-chain amyloidosis, AL cardiac amyloidosis is the primary form of the disease, in which plasma cells in the bone marrow produce misfolded proteins. This can cause fibrils to be deposited in different organs, including the heart, and is sometimes found in multiple myeloma patients. AL amyloidosis can develop quickly, causing significant organ damage and requiring an immediate course of chemotherapy.ATTR Amyloidosis
ATTR amyloidosis occurs when the protein transthyretin is misfolded and then deposited in the heart. ATTR amyloidosis is further divided into two sub-types:
- Wild-type ATTR: This is commonly found in men over the age of 65, and was formerly known as “senile systemic amyloidosis.” It happens when normal protein cells misfold due to age.
- Hereditary ATTR: This is a genetic mutation that produces unstable transthyretin protein cells.
Signs & Symptoms of Cardiac Amyloidosis
Fatigue
Shortness of Breath
Swelling
Heart Palpitations
Neuropathy
Carpal Tunnel Symptoms
How Cardiac Amyloidosis Is Diagnosed
There are various types and causes of amyloidosis, which can make this condition difficult to diagnose and treat.
At Houston Methodist, heart specialists use several imaging procedures to diagnose cardiac amyloidosis:
- Electrocardiogram (EKG/ECG)
- Echocardiogram
- Cardiac magnetic resonance imaging (MRI)
- Nuclear PYP scan
We also perform genetic testing to help diagnose TTR amyloidosis, and often use a cardiac tissue biopsy to confirm a cardiac amyloidosis diagnosis.
With an early diagnosis, we can often treat the source of cardiac amyloidosis, limiting further damage to your heart. When diagnosis occurs later during disease development, when there is already extensive amyloid deposition in the heart, treatment options are more limited.
Treatment Options for Cardiac Amyloidosis
There are various types of amyloidosis, and the treatment options differ considerably depending on the underlying cause and whether organs other than the heart are involved.
If you have AL amyloidosis, your cardiologist will work closely with your hematologist to treat the underlying cause of your condition.
If you have TTR amyloidosis, your cardiologist may recommend a medication that either helps block the protein involved from sticking to your heart or decreases its production altogether.
Non-Surgical Treatments
While the specific treatment course will vary based on the type of cardiac amyloidosis, there are several medications and drug therapies used to treat the disease, including:
- Stabilizers: Medications like Tafamidis (Vyndamax/Vyndaqel) that bind with the TTR protein to prevent it from misfolding.
- Silencers: Drugs like vutrisiran (Amvuttra) that keep the liver from producing the TTR protein.
- Chemotherapy: Drug therapy that targets the plasma cells involved in AL amyloidosis.
- Diuretics: Medication used to reduce swelling and treat heart failure symptoms.
- Blood thinners: Anticoagulation drugs used to prevent blood clots, an ongoing risk for amyloidosis patients.
- Stem cell transplant: Similar to a blood transfusion, in which healthy stem cells are placed into the bloodstream.
Surgical Treatments
When conservative, medication-based treatment is not an option, your cardiologist may recommend one of the following surgical procedures:
- Implantable cardioverter-defibrillator (ICD): A device used to regulate the heart’s rhythm.
- Pacemaker: A device that delivers electrical pulses to keep the heart beating normally.
- Heart transplant: May be necessary in extreme cases, (possibly with dual- or multi-organ transplant)